- R. G. Walters
(Section of Genomic Medicine, Imperial College London, London W12 0NN, UK.
Imperial College London, London W2 1PG, UK.)
- S. Jacquemont
(Service de Génétique Médicale, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.)
- A. Valsesia
(Departement de Génétique Médicale, Université de Lausanne, CH-1015 Lausanne, Switzerland.
Ludwig Institute for Cancer Research, Université de Lausanne, CH-1015 Lausanne, Switzerland.
Swiss Institute of Bioinformatics, CH-1015 Lausanne, Switzerland.)
- A. J. de Smith
(Section of Genomic Medicine, Imperial College London, London W12 0NN, UK.)
- D. Martinet
(Service de Génétique Médicale, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.)
- J. Andersson
(Section of Genomic Medicine, Imperial College London, London W12 0NN, UK.)
- M. Falchi
(Section of Genomic Medicine, Imperial College London, London W12 0NN, UK.)
- F. Chen
(Brain Mind Institute, École Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.)
- J. Andrieux
(Laboratoire de Génétique Médicale, Centre Hospitalier Régional Universitaire, 59000 Lille, France.)
- S. Lobbens
(CNRS 8090-Institute of Biology, Pasteur Institute, 59800 Lille, France.)
- B. Delobel
(Centre de Génétique Chromosomique, Hôpital Saint-Vincent de Paul, GHICL, 59020 Lille, France.)
- F. Stutzmann
(CNRS 8090-Institute of Biology, Pasteur Institute, 59800 Lille, France.)
- J. S. El-Sayed Moustafa
(Section of Genomic Medicine, Imperial College London, London W12 0NN, UK.)
- J.-C. Chèvre
(CNRS 8090-Institute of Biology, Pasteur Institute, 59800 Lille, France.)
- C. Lecoeur
(CNRS 8090-Institute of Biology, Pasteur Institute, 59800 Lille, France.)
- V. Vatin
(CNRS 8090-Institute of Biology, Pasteur Institute, 59800 Lille, France.)
- S. Bouquillon
(Laboratoire de Génétique Médicale, Centre Hospitalier Régional Universitaire, 59000 Lille, France.)
- J. L. Buxton
(Section of Genomic Medicine, Imperial College London, London W12 0NN, UK.)
- O. Boute
(Service de Génétique Clinique, Hôpital Jeanne de Flandre, Centre Hospitalier Universitaire de Lille, 59000 Lille, France.)
- M. Holder-Espinasse
(Service de Génétique Clinique, Hôpital Jeanne de Flandre, Centre Hospitalier Universitaire de Lille, 59000 Lille, France.)
- J.-M. Cuisset
(Service de Neuropédiatrie, Centre Hospitalier Régional Universitaire, 59000 Lille, France.)
- M.-P. Lemaitre
(Service de Neuropédiatrie, Centre Hospitalier Régional Universitaire, 59000 Lille, France.)
- A.-E. Ambresin
(Unité Multidisciplinaire de Santé des Adolescents, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.)
- A. Brioschi
(Service de Neuropsychologie et de Neuroréhabilitation, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.)
- M. Gaillard
(Service de Génétique Médicale, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.)
- V. Giusti
(Service d’Endocrinologie, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.)
- F. Fellmann
(Service de Génétique Médicale, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.)
- A. Ferrarini
(Service de Génétique Médicale, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.)
- N. Hadjikhani
(Brain Mind Institute, École Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.
Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA.)
- D. Campion
(INSERM, U614, Faculté de Médecine, 76183 Rouen, France.)
- A. Guilmatre
(INSERM, U614, Faculté de Médecine, 76183 Rouen, France.)
- A. Goldenberg
(Service de Génétique, Centre Hospitalier Universitaire de Rouen, 76031 Rouen, France.)
- N. Calmels
(Laboratoire de Diagnostic Génétique, Nouvel Hôpital civil, 67091 Strasbourg, France.)
- J.-L. Mandel
(Laboratoire de Diagnostic Génétique, Nouvel Hôpital civil, 67091 Strasbourg, France.)
- C. Le Caignec
(Centre Hospitalier Universitaire Nantes, Service de Génétique Médicale, 44093 Nantes, France.
INSERM, UMR915, L’Institut du Thorax, 44007 Nantes, France.)
- A. David
(Centre Hospitalier Universitaire Nantes, Service de Génétique Médicale, 44093 Nantes, France.)
- B. Isidor
(Centre Hospitalier Universitaire Nantes, Service de Génétique Médicale, 44093 Nantes, France.)
- M.-P. Cordier
(Service de Génétique, Hospices Civils de Lyon, Hôpital de l’Hotel Dieu, 69288 Lyon, France.)
- S. Dupuis-Girod
(Service de Génétique, Hospices Civils de Lyon, Hôpital de l’Hotel Dieu, 69288 Lyon, France.)
- A. Labalme
(Service de Génétique, Hospices Civils de Lyon, Hôpital de l’Hotel Dieu, 69288 Lyon, France.)
- D. Sanlaville
(Service de Génétique, Hospices Civils de Lyon, Hôpital de l’Hotel Dieu, 69288 Lyon, France.
EA 4171, Université Claude Bernard, 69622 Lyon, France.)
- M. Béri-Dexheimer
(Laboratoire de Génétique, Centre Hospitalier Universitaire, Nancy Université, 54511 Vandoeuvre les Nancy, France.)
- P. Jonveaux
(Laboratoire de Génétique, Centre Hospitalier Universitaire, Nancy Université, 54511 Vandoeuvre les Nancy, France.)
- B. Leheup
(Laboratoire de Génétique, Centre Hospitalier Universitaire, Nancy Université, 54511 Vandoeuvre les Nancy, France.
EA4368 Medical School Nancy, Université Henri Poincaré, 54003 Nancy, France.)
- K. Õunap
(United Laboratories, Tartu University Children’s Hospital, 50406 Tartu, Estonia.)
- E. G. Bochukova
(University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK.)
- E. Henning
(University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK.)
- J. Keogh
(University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK.)
- R. J. Ellis
(North West Thames Regional Genetics Service, Northwick Park & St Marks Hospital, Harrow HA1 3UJ, UK.)
- K. D. MacDermot
(North West Thames Regional Genetics Service, Northwick Park & St Marks Hospital, Harrow HA1 3UJ, UK.)
- M. M. van Haelst
(North West Thames Regional Genetics Service, Northwick Park & St Marks Hospital, Harrow HA1 3UJ, UK.
†Present address: Department of Medical Genetics, University Medical Centre Utrecht, 3584 EA Utrecht, The Netherlands.)
- C. Vincent-Delorme
(Centre Hospitalier D’Arras, Génétique Médicale, 62000 Arras, France.)
- G. Plessis
(Service de Génétique Médicale, Centre Hospitalier Universitaire Clemenceau, 14033 Caen, France.)
- R. Touraine
(Centre Hospitalier Universitaire–Hôpital Nord, Service de Génétique, 42055 Saint Étienne, France.)
- A. Philippe
(Université Paris Descartes, Hôpital Necker-Enfants Malades, 75015 Paris, France.)
- V. Malan
(Université Paris Descartes, Hôpital Necker-Enfants Malades, 75015 Paris, France.)
- M. Mathieu-Dramard
(Service de Génétique Clinique, Centre Hospitalier Universitaire, 80054 Amiens, France.)
- J. Chiesa
(Laboratoire de Cytogénétique, Centre Hospitalier Universitaire Caremeau, 30029 Nîmes, France.)
- B. Blaumeiser
(University Hospital & University of Antwerp, 2650 Edegem, Belgium.)
- R. F. Kooy
(University Hospital & University of Antwerp, 2650 Edegem, Belgium.)
- R. Caiazzo
(INSERM U859, Biotherapies for Diabetes, 59045 Lille, France.
Université Lille Nord de France, Centre Hospitalier Universitaire Lille, 59037 Lille, France.)
- M. Pigeyre
(Université Lille Nord de France, Centre Hospitalier Universitaire Lille, 59037 Lille, France.)
- B. Balkau
(INSERM U780-IFR69, 94807 Villejuif, France.)
- R. Sladek
(McGill University and Genome Quebec Innovation Centre, Montreal H3A 1A4, Canada.
McGill University, Montreal H3A 1B1, Canada.)
- S. Bergmann
(Departement de Génétique Médicale, Université de Lausanne, CH-1015 Lausanne, Switzerland.
Swiss Institute of Bioinformatics, CH-1015 Lausanne, Switzerland.)
- V. Mooser
(GlaxoSmithKline, Philadelphia, Pennsylvania 19101, USA.)
- D. Waterworth
(GlaxoSmithKline, Philadelphia, Pennsylvania 19101, USA.)
- A. Reymond
(The Center for Integrative Genomics, University of Lausanne, CH-1015 Lausanne, Switzerland.)
- P. Vollenweider
(Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.)
- G. Waeber
(Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.)
- A. Kurg
(Institute of Molecular and Cell Biology, University of Tartu, 51010 Tartu, Estonia.)
- P. Palta
(Institute of Molecular and Cell Biology, University of Tartu, 51010 Tartu, Estonia.)
- T. Esko
(Estonian Genome Project, University of Tartu, 50410 Tartu, Estonia.
Estonian Biocentre, 51010 Tartu, Estonia.)
- A. Metspalu
(Estonian Genome Project, University of Tartu, 50410 Tartu, Estonia.
Estonian Biocentre, 51010 Tartu, Estonia.)
- M. Nelis
(Estonian Genome Project, University of Tartu, 50410 Tartu, Estonia.
Estonian Biocentre, 51010 Tartu, Estonia.)
- P. Elliott
(Imperial College London, London W2 1PG, UK.)
- A.-L. Hartikainen
(University of Oulu, 90220 Oulu, Finland.)
- M. I. McCarthy
(Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford OX3 7LJ, UK.
Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.)
- L. Peltonen
(Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.
Institute of Molecular Medicine, Biomedicum, 00290 Helsinki, Finland.
Massachusetts Institute of Technology, The Broad Institute, Cambridge, Massachusetts 02142, USA.)
- L. Carlsson
(The Sahlgrenska Academy, 413 45 Göteborg, Sweden.)
- P. Jacobson
(The Sahlgrenska Academy, 413 45 Göteborg, Sweden.)
- L. Sjöström
(The Sahlgrenska Academy, 413 45 Göteborg, Sweden.)
- N. Huang
(Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.)
- M. E. Hurles
(Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.)
- S. O’Rahilly
(University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK.)
- I. S. Farooqi
(University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK.)
- K. Männik
(Institute of Molecular and Cell Biology, University of Tartu, 51010 Tartu, Estonia.)
- M.-R. Jarvelin
(Imperial College London, London W2 1PG, UK.
National Public Health Institute, 90101 Oulu, Finland.
Institute of Health Sciences and Biocenter Oulu, University of Oulu, 90220 Oulu, Finland.)
- F. Pattou
(INSERM U859, Biotherapies for Diabetes, 59045 Lille, France.
Université Lille Nord de France, Centre Hospitalier Universitaire Lille, 59037 Lille, France.)
- D. Meyre
(CNRS 8090-Institute of Biology, Pasteur Institute, 59800 Lille, France.)
- A. J. Walley
(Section of Genomic Medicine, Imperial College London, London W12 0NN, UK.)
- L. J. M. Coin
(Imperial College London, London W2 1PG, UK.)
- A. I. F. Blakemore
(Section of Genomic Medicine, Imperial College London, London W12 0NN, UK.)
- P. Froguel
(Section of Genomic Medicine, Imperial College London, London W12 0NN, UK.
CNRS 8090-Institute of Biology, Pasteur Institute, 59800 Lille, France.)
- J. S. Beckmann
(Service de Génétique Médicale, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.
Departement de Génétique Médicale, Université de Lausanne, CH-1015 Lausanne, Switzerland.)